Our study examined whether common variants of obesity-associated genes FTO, MC4R, BDNF, and CREB1 moderated the effects of a lifestyle intervention on weight change among breast cancer survivors.
151 breast cancer survivors with a body mass index ≥ 25 kg/m2 were randomly assigned to a 6-month weight loss intervention or usual care group. Genotyping of FTO rs9939609, MC4R rs6567160, BDNF rs11030104, CREB1 rs17203016 was performed. Linear mixed models were used including the main effects of genotype (assuming a dominant genetic model), treatment arm on weight and percent body fat changes, and genotype by treatment interaction variable. All statistical tests were evaluated against a Bonferroni-corrected alpha of 0.0125.
Women in the intervention group achieved significantly greater weight loss than the usual care group (5.9% vs 0.4%, p < 0.001), regardless of genotype. Changes in weight and percent body fat did not differ significantly between carriers of the FTO rs9939609, MC4R rs6567160, BDNF rs11030104, and CREB1 rs17203016 risk alleles compared to non-carriers (p-interaction > 0.0125 for each single-nucleotide polymorphisms).
Women who are genetically predisposed to obesity and recently diagnosed with breast cancer may achieve significant and clinically meaningful weight loss through healthy eating and exercise.
Clinical Trial Registration: NCT02863887 (Date of Registration: August 11, 2016); NCT02110641 (Date of Registration: April 10, 2014)
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Although data sharing will not be available in a public database, deidentified study data and study protocol will be shared upon reasonable request up until December 31, 2025, by contacting the corresponding author.
The study statistical analysis plan will be shared upon reasonable request up until December 31, 2025, by contacting the corresponding author.
Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH (2013) Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol: Off J Eur Soc Med Oncol 24(10):2506–2514. https://doi.org/10.1093/annonc/mdt224
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH et al (2016) Cancer treatment and survivorship statistics, 2016. CA: Cancer J Clin 66(4):271–289. https://doi.org/10.3322/caac.21349
Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL et al (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prevent: Publ Am Assoc Cancer Res Cospons Am Soc Prevent Oncol 14(7):1686–1691. https://doi.org/10.1158/1055-9965.Epi-05-0042
Warren LE, Ligibel JA, Chen YH, Truong L, Catalano PJ, Bellon JR (2016) Body mass index and locoregional recurrence in women with early-stage breast cancer. Ann Surg Oncol 23(12):3870–3879. https://doi.org/10.1245/s10434-016-5437-3
Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A et al (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol: Off J Eur Soc Med Oncol 25(10):1901–1914. https://doi.org/10.1093/annonc/mdu042
Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL et al (2012) Nutrition and physical activity guidelines for cancer survivors. CA: Cancer J Clin 62(4):243–74. https://doi.org/10.3322/caac.21142
Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W (2014) Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev 15(9):749–768. https://doi.org/10.1111/obr.12190
Playdon M, Thomas G, Sanft T, Harrigan M, Ligibel J, Irwin M (2013) Weight loss intervention for breast cancer survivors: a systematic review. Curr Breast Cancer Rep 5(3):222–246. https://doi.org/10.1007/s12609-013-0113-0
van der Klaauw AA, Farooqi IS (2015) The hunger genes: pathways to obesity. Cell 161(1):119–132. https://doi.org/10.1016/j.cell.2015.03.008
Maes HH, Neale MC, Eaves LJ (1997) Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27(4):325–351. https://doi.org/10.1023/a:1025635913927
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR et al (2015) Genetic studies of body mass index yield new insights for obesity biology. Nature 518(7538):197–206. https://doi.org/10.1038/nature14177
Peng S, Zhu Y, Xu F, Ren X, Li X, Lai M (2011) FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med 9:71. https://doi.org/10.1186/1741-7015-9-71
Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385(6612):165–168. https://doi.org/10.1038/385165a0
Valette M, Bellisle F, Carette C, Poitou C, Dubern B, Paradis G, et al (2005) Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review. Int J Obes 2013;37(8):1027–1035. https://doi.org/https://doi.org/10.1038/ijo.2012.169.
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (New York, NY) 316(5826):889–894. https://doi.org/10.1126/science.1141634
Haupt A, Thamer C, Heni M, Tschritter O, Machann J, Schick F et al (2009) Impact of variation near MC4R on whole-body fat distribution, liver fat, and weight loss. Obesity (Silver Spring, Md) 17(10):1942–1945. https://doi.org/10.1038/oby.2009.233
Scherag A, Dina C, Hinney A, Vatin V, Scherag S, Vogel CI et al (2010) Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet 6(4):e1000916. https://doi.org/10.1371/journal.pgen.1000916
Xi B, Chandak GR, Shen Y, Wang Q, Zhou D (2012) Association between common polymorphism near the MC4R gene and obesity risk: a systematic review and meta-analysis. PLoS ONE 7(9):e45731. https://doi.org/10.1371/journal.pone.0045731
Yu K, Li L, Zhang L, Guo L, Wang C (2020) Association between MC4R rs17782313 genotype and obesity: a meta-analysis. Gene 733:144372. https://doi.org/10.1016/j.gene.2020.144372
Sandrini L, Di Minno A, Amadio P, Ieraci A, Tremoli E, Barbieri SS. Association between Obesity and Circulating Brain-Derived Neurotrophic Factor (BDNF) Levels: Systematic Review of Literature and Meta-Analysis. Int J Mol Sci 2018;19(8). https://doi.org/https://doi.org/10.3390/ijms19082281.
Lin L, Hales CM, Garber K, Jin P (2014) Fat mass and obesity-associated (FTO) protein interacts with CaMKII and modulates the activity of CREB signaling pathway. Hum Mol Genet 23(12):3299–3306. https://doi.org/10.1093/hmg/ddu043
Bouchard C (2008) Gene-environment interactions in the etiology of obesity: defining the fundamentals. Obesity (Silver Spring, Md) 16(Suppl 3):S5-s10. https://doi.org/10.1038/oby.2008.528
Sonestedt E, Roos C, Gullberg B, Ericson U, Wirfält E, Orho-Melander M (2009) Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am J Clin Nutr 90(5):1418–1425. https://doi.org/10.3945/ajcn.2009.27958
Haupt A, Thamer C, Machann J, Kirchhoff K, Stefan N, Tschritter O et al (2008) Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity (Silver Spring, Md) 16(8):1969–1972. https://doi.org/10.1038/oby.2008.283
Ahmad T, Lee IM, Paré G, Chasman DI, Rose L, Ridker PM et al (2011) Lifestyle interaction with fat mass and obesity-associated (FTO) genotype and risk of obesity in apparently healthy U.S. women. Diabetes care. 34(3):675–80. https://doi.org/10.2337/dc10-0948
Merritt DC, Jamnik J, El-Sohemy A (2018) FTO genotype, dietary protein intake, and body weight in a multiethnic population of young adults: a cross-sectional study. Genes Nutr 13:4. https://doi.org/10.1186/s12263-018-0593-7
Lappalainen TJ, Tolppanen AM, Kolehmainen M, Schwab U, Lindström J, Tuomilehto J et al (2009) The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight: the Finnish Diabetes Prevention Study. Obesity (Silver Spring, Md) 17(4):832–836. https://doi.org/10.1038/oby.2008.618
Grau K, Hansen T, Holst C, Astrup A, Saris WH, Arner P, et al. Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. International journal of obesity (2005). 2009;33(11):1227–34. https://doi.org/https://doi.org/10.1038/ijo.2009.159.
Zhang X, Qi Q, Zhang C, Smith SR, Hu FB, Sacks FM et al (2012) FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes 61(11):3005–3011. https://doi.org/10.2337/db11-1799
Razquin C, Martinez JA, Martinez-Gonzalez MA, Bes-Rastrollo M, Fernández-Crehuet J, Marti A. A 3-year intervention with a Mediterranean diet modified the association between the rs9939609 gene variant in FTO and body weight changes. Int J Obes (2005). 2010;34(2):266–72. https://doi.org/https://doi.org/10.1038/ijo.2009.233.
Livingstone KM, Celis-Morales C, Papandonatos GD, Erar B, Florez JC, Jablonski KA, et al. FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials. BMJ (Clinical research ed). 2016;354:i4707. Epub 2016/09/22. https://doi.org/https://doi.org/10.1136/bmj.i4707
Harrigan M, Cartmel B, Loftfield E, Sanft T, Chagpar AB, Zhou Y et al (2016) Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) Study. J Clin Oncol: 34(7):669–676. https://doi.org/10.1200/jco.2015.61.6375
Kilpeläinen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, Demerath E, et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 2011;8(11):e1001116. Epub 2011/11/10. doi: https://doi.org/10.1371/journal.pmed.1001116.
Chen Y, Liu H, Wang L, Zhou T, Liang Z, Li W et al (2019) Lifestyle intervention modifies the effect of the MC4R genotype on changes in insulin resistance among women with prior gestational diabetes: Tianjin Gestational Diabetes Mellitus Prevention Program. Am J Clin Nutr 110(3):750–758. https://doi.org/10.1093/ajcn/nqz121
Xiang L, Wu H, Pan A, Patel B, Xiang G, Qi L et al (2016) FTO genotype and weight loss in diet and lifestyle interventions: a systematic review and meta-analysis. Am J Clin Nutr 103(4):1162–1170. https://doi.org/10.3945/ajcn.115.123448
Zlatohlavek L, Vrablik M, Motykova E, Ceska R, Vasickova L, Dlouha D et al (2013) FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention. Clin Biochem 46(4–5):313–316. https://doi.org/10.1016/j.clinbiochem.2012.11.017
Qi Q, Kilpeläinen TO, Downer MK, Tanaka T, Smith CE, Sluijs I et al (2014) FTO genetic variants, dietary intake and body mass index: insights from 177,330 individuals. Hum Mol Genet 23(25):6961–6972. https://doi.org/10.1093/hmg/ddu411
Wang K, Li WD, Zhang CK, Wang Z, Glessner JT, Grant SF et al (2011) A genome-wide association study on obesity and obesity-related traits. PLoS ONE 6(4):e18939. https://doi.org/10.1371/journal.pone.0018939
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403. https://doi.org/10.1056/NEJMoa012512
Loos RJF, Janssens A (2017) predicting polygenic obesity using genetic information. Cell Metab 25(3):535–543. https://doi.org/10.1016/j.cmet.2017.02.013
Woehning A, Schultz JH, Roeder E, Moeltner A, Isermann B, Nawroth PP, et al. The A-allele of the common FTO gene variant rs9939609 complicates weight maintenance in severe obese patients. International journal of obesity (2005). 2013;37(1):135–9. https://doi.org/https://doi.org/10.1038/ijo.2012.14.
Matsuo T, Nakata Y, Hotta K, Tanaka K (2014) The FTO genotype as a useful predictor of body weight maintenance: Initial data from a 5-year follow-up study. Metabolism 63(7):912–917. https://doi.org/10.1016/j.metabol.2014.03.013
Papandonatos GD, Pan Q, Pajewski NM, Delahanty LM, Peter I, Erar B et al (2015) Genetic predisposition to weight loss and regain with lifestyle intervention: analyses from the diabetes prevention program and the look ahead randomized controlled trials. Diabetes 64(12):4312–4321. https://doi.org/10.2337/db15-0441
We are thankful to the LEAN participants for their time and dedication with the LEAN study.
Supported by American Institute for Cancer Research and in part by a grant from the Breast Cancer Research Foundation. Also supported in part by the Yale Cancer Center Support Grant P30 CA016359 and the Clinical and Translational Science Award Grant Number UL1 TR000142 from the National Center for Advancing Translational Science, a component of the National Institutes of Health.
Conflict of interest
The authors declared no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Nguyen, T., Irwin, M.L., Dewan, A.T. et al. Examining the effect of obesity-associated gene variants on breast cancer survivors in a randomized weight loss intervention. Breast Cancer Res Treat 187, 487–497 (2021). https://doi.org/10.1007/s10549-021-06151-5
- Breast Cancer
- Weight loss